Single logo
LoginSign Up

Pharmaceutical Data Integrity and Computer System Validation Audit Checklist

A comprehensive checklist for auditing data integrity practices and computer system validation in pharmaceutical operations to ensure regulatory compliance and data reliability.

Pharmaceutical Data Integrity and Computer System Validation Audit Checklist

by: audit-now
4.5

Get Template

About This Checklist

Data integrity and validated computer systems are fundamental to ensuring the reliability and trustworthiness of pharmaceutical operations. This Pharmaceutical Data Integrity and Computer System Validation Audit Checklist is an essential tool for evaluating the robustness of data management practices and the compliance of computerized systems used in pharmaceutical processes. By systematically assessing data governance, system validation, access controls, audit trails, and data lifecycle management, this checklist helps maintain regulatory compliance and data reliability across all computerized systems. Regular implementation of this comprehensive audit process can significantly reduce risks associated with data manipulation, enhance the quality of regulatory submissions, and support overall confidence in pharmaceutical research and manufacturing data.

Learn more

Industry

Healthcare

Standard

21 CFR Part 11 - Electronic Records

Workspaces

Research Facilities

Occupations

IT Quality Assurance Specialist
Computer System Validation Expert
Data Integrity Officer
Quality Control Manager
Regulatory Compliance Specialist
1
Is access to the system controlled and restricted to authorized personnel only?
2
Is the audit trail feature enabled on the system?
3
Describe the data lifecycle management process in place for the system.
4
How often is training on data integrity principles conducted?
Min: 1
Target: Quarterly
Max: 12
5
Is the validation documentation complete and up to date?
6
What is the date of the last validation performed on the system?
7
What was the error rate observed during the last validation process?
Min: 0
Target: 0%
Max: 100
8
Provide a description of the change control process implemented for the system.
9
Is there a documented data governance policy available?
10
Have regular data integrity audits been conducted as per the governance policy?
11
What is the date of the next scheduled data integrity audit?
12
Describe the training provided on data governance and integrity principles.
13
Is the system compliant with applicable regulatory requirements?
14
How many non-conformities were identified during the last audit?
Min: 0
Target: 0
Max: 100
15
When was the last compliance review conducted on the system?
16
Describe the corrective actions taken to address any identified issues.
17
Does the data management process adhere to ALCOA+ principles?
18
Are regular data audits conducted to verify data integrity?
19
What is the average turnaround time for data corrections?
Min: 0
Target: 1 day
Max: 72
20
Describe the procedures in place for responding to data integrity incidents.

FAQs

These audits should be conducted at least annually for critical systems. Additionally, audits should be performed after significant system changes, upgrades, or when new systems are implemented.

This checklist covers data governance policies, system validation documentation, access control measures, audit trail reviews, data backup and recovery processes, change management procedures, and compliance with ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available).

These audits are typically conducted by IT quality assurance specialists, computer system validation experts, or qualified auditors with expertise in both pharmaceutical regulations and information technology.

The checklist ensures that all aspects of data management and computerized systems meet regulatory requirements, including FDA's 21 CFR Part 11 and EMA's guidance on data integrity, which are crucial for maintaining the validity and reliability of pharmaceutical data.

If data integrity issues are identified, actions should include immediate assessment of the impact on product quality and patient safety, investigation of the root cause, implementation of corrective measures, potential data remediation, system revalidation if necessary, and enhanced monitoring and training. All actions must be meticulously documented and reported to management.

Benefits of Pharmaceutical Data Integrity and Computer System Validation Audit Checklist

Ensures compliance with data integrity regulations and GAMP 5 guidelines

Reduces risks of data manipulation, loss, or unauthorized access

Improves reliability and trustworthiness of pharmaceutical data

Enhances the quality and acceptability of regulatory submissions

Facilitates early detection of potential data integrity issues